Blehm, R. (2006). Physical therapy and other nopharmaologic approaches to fibromyalgia management. Current Pain and Headache Reports, 10, 333 - 338.
Brodsky, MA, Hogarth, P, Nutt, JG. (2006). Off-off rebound dyskinesia in subthalamic nucleus deep brain stimulation of Parkinson's disease. Movement Disorders, 21, 1487 - 1490.
Brodsky, MA, McAnulty, J, Zipes, DP, Baesssler, C, Hallstrom, A. (2006). A history of heart failure predicts arrhythmia treatment efficacy: Data from the Antiarrythimics versus implantable
defibrillators (AVID) study. American Heart Journal, 152, 724 - 730.
Elbaz, A, Nelson,L, M, Payami, H, Loannidis, J, Fiske, BF, Annesi, G, Belin, AC, Factor, SQ, Ferrarese, C, Hadjigeorgiou, GM, Higgins, DS, Kawakami, H, Kruger,
R, Marder, KS, Mayeux, RP, Mellick, GD, Nutt, JG, Ritz, B, Samii, A, Tanner, CM, Van Broeckhoven, C, Van Den Eeden, SK, Wirdefeldt, K, Zabetian, CP, Dehem, M, Montimurro, JS, Sourthwick, A, Myers, RM, Rickalinos, TA. (2006).
Lack of replication of thirteen, single-nucleotide polymorphisms, implicated in Parkinson's disease: a large-scale international study. The Lancet Neurology, 5, 917 - 923.
Jacobs, JV, Horak, FB, Van Tran, K, Nutt, JG. (2006). An alternative clinical postural stability test for patients with parkinson's disease. Journal of Neurology,,
Kay, DM, Bird, TD, Zabetian, CP, Factor, SA, Samii, A, Higgins, DS, Nutt, JG, Roberts, JW, Griffith, A, Leis, B, Montimurro, JS, Philpott, S, Payami, H. (2006). Validity
and utility of a LRRK2 G2019S mutation test for the diagnosis of Parkinson's disease. Genetic Testing, 10, 221 - 227.
Kelly, VE, Samii, A, Slimp, JC, Price, R, Goodkin, R, Shumway-Cook, A. (2006). Gait changes in response to subthalamic nucleus stimulation in people
with Parkinson's disease: A case series report. Journal of Neurologic Physical Therapy, 30, 184 - 194.
Moro, E, Nutt, JG, Stacy, M, Turner, D, Wooten, GF. (2006). GDNF in treatment of Parkinson's disease: response to editorial. The Lancet Neurology, 5, 200 - 202.
Oskouian, RJ, Samii, A, Laws, ER, Jr,. (2006) The chraniopharyngioma. Frontiers of Hormone Research, 34, 105 - 126.
Pan, S Wang, Y, Quinn, JF, Peskind, ER, Walchunas, D, Wimberger, JT, Jin, J, Li, JG, Zhu, D, Pan, C, Zhang, J. (2006). Identification of glycoproteins in human cerebrospinal fluid with a complimentary proteomic approach. Journal Proteome Research, 5, 2769 - 2779.
Reisekse, RG, Li, G, Petrie, EC, Leverenz, JB, Vavrek, D, Buletic, S, Albers, JJ, Montine, TJ, Lee, VM, Lee, M, Seubert, P, Galasko,
Schellenberg, GD, Hazzard, WR, Peskind, ER. (2006). Effect of statins on Alzheimer's disease biomarkers in cerebrospinal fluid. Journal of Alzheimer's disease. 10, 399 - 406.
Tsuang, D, Simpson, K, Larson, EB, Peskind, E, Kukull, W, Bowen, JB, McCormick, W, Teri, L, Montine, T, Thompson, ML, Leverenz, JB. (2006). Predicting lewy body pathology in a community-based sample with clinical diagnosis for Alzheimer's disease. Journal of Geriatric Psychiatry & Neurology, 19, 195 - 201.
January to September 2007
Bowman, GI, Kaye, JA, Moore, M, Waichunas, BA, Carlson, NE, Quinn, JF. (2007). Blood-brian barrier impairment in Alzheimer's disease: Stability and functional significance. Neurology, 68, 1809 - 1814.
Chan, PL, Nutt, JG, Holford, NH. (2007). Jourbert syndrome surviving to adulthood associated with progressive movement disorder. Pharmacological Research, 24, 191 - 802.
Freeman, K, Gregory, A, Turner, A, Blasco, P, Hogarth, P, Hayflick, S. (2007). Intellectual and adaptive behavior functioning in pantothenate kinase-associated neurodegeneration. Journal of Intellectual Disability Research, 51, 417 - 426.
Gunzler, SA, Stoessl, AJ, Egan, RA, Weleber, RG, Wang, P, Nutt, JG. (2007). Jourbert syndrome surviving to adulthood associated with progressive movement disorder. Movement Disorders, 22, 262 - 264.
Leverenz, JB, Umar, I, Wang, Q, Montine, TJ, McMillan, PJ, Tsuang, DW, Jin, J, Pan, C, Shin, J, Zhu, D, Zhange, J. (2007). Proteomic indentificiation of novel proteins in cortical lewy bodies. Brain Pathology, 17, 139 - 145.
Leverenz, JB, Yu, CE, Montine, TJ, Steinbart, E, Bekris, LM, Zabetian, C, Kwong, LK, Lee, VM-Y, Schellengberg, GD, Bird, TD. (2007). A novel progranulin mutation associated with variable clinical presentation and tau TDP43 and alpha-synuclein pathology. Brain, 130, 1360 - 1374.
Lippa, CF, Duda, JE, Grossman, M, Hurtig, HI, Aarsland,, D, Boeve, BF, Brooks, DJ, Dickson, DW, Dubois, B, Emre, M, Fahn, S, Farmer, JM, Galasko, D, Glavin, JE, Goetz, CG, Growdon, JH, Gwinn-Hardy, KA, Hardy, J, Heutink, P, Iwatsubo, T, Kosaka, K, Lee, VM, Leverenz, JB, Masilah, E, McKeith, IG, Nussbaum, RL, Olanow, CW, Ravina, BM, Singleton, AB, Tanner, CM, Trojanowski, JQ, Wszokek, ZK. (2007). DLB and Pdd boundary issues: Diagnosis treatment molecular pathology and biomarkers. Neurology, 68, 812 -819.
Nutt, JG. (2007). Continuous dopaminergic stimulation: Is it the answer to the motor complications of levodopa?. Movement Disorders, 22, 1 - 9.
Nutt, JG, Carter, JH, Carlson, NE. (2007). Effects of methylphenidate on response to oral levodopa: A double-blind clinical trial. Archives of Neurology, 64, 319 - 323.
Pan, S, Zhu, D, Quinn, JF, Peskind, ER, Montine, TJ, Lin, B, Goodlett, DR, Taylor, G, Eng, J, Zhang, J. (2007). A combined dataset of human cerebrospinal fluid proteins identified by multidimensional chromatography and tandem amss spectrometry. Proteomics, 7, 469 - 473.
Solomon, AC, Stout, JC, Johnson, SA, Langbehn, DR, Aylward, EH, Brandt, J, Ross, CA, Beglinger, L, Hayden, MR, Keiburtz, K, Kayson, E, Julian-Baros, E, Duff, K, Guttman, M, Nance, M, Oakes, D, Shoulson, I, Penziner, E, Pausen, JS. (2007). Verbal episodic memory declines prior to diagnosis in Huntington's disease. Neuropsychologia, 45, 1767 - 1776.
Szot, P, White, SS, Greenup, JL, Leverenz, JB, Peskind, ER, Raskind, MA. (2007). Changes in adrenoreceptors in the prefrontal cortex of subjects with dementia: Evidence of compensatory changes. Neuroscience, 146, 471 - 274.
Walker, M, Kim, H, Samii, A. (2007). Holmes-like tremor of the lower extremity following brainstem hemorrhage. Movement Disorders, 22, 272 - 274.
Wu, Y-N, Johnson, SW. (2007). Rotenone potentiates NMDA currents in substantia nigra dopamine neurons. Neuroscience Letters, 421, 96 - 100.
Zhu, Z-T, Munhall, AC, Johnson, SW. (2007). Tyramine excites rat subthalamic neurons in vitrroo by a dopamine-dependent mechanism. Neuropharmacology, 52, 1169 - 1178.
Brickell, KL, Leverenz, JB, Steinbart, EJ, Rumbaugh, M, Schellenberg, GD, Nochlin, D, Lampe, TH, Holm, IE, Vedeerlin, V, Yuan, W, Bird, TD, (AOP). Clinicopahtological concordance and discordance in three monozygotic twin pairs with familial Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry.
Chun, LS, Samii, A, Hutter, CM, Grifftith, A, Roberts, JW, Leis, BC, Mosley, AD, Wander, PL, Edwards, KL, Payami, H, Zabetian, CP, (AOP). The DBH -1021C-->T does not modify risk or age at onset in Parkinson's disease. Annuals of Neurology.
Etimann, M, Carleton, BC, Samii, A. (AOP). Nonsteroidal anti-inflammatory drugs and the risk of developing Parkinson's disease: A retrospective cohort study. Journal of Clinical Neuroscience.
Hogarth, P, Lovercic, L, Krainc, D. (AOP). Sodium phenylbutyrate in Huntington disease: A dose-finding study. Movement Disorders.
Nakashima-Yashuda, H, Uryu, K, Robinson, J, Xie, SX, Hurtig, H, Duda, JE, Arnold, SE, Siderowf, A, Gorssman, M, Leverenz, JB, Woltjer, R, Lopez, OL, Hamilton, R, Tsuang, DW, Galasko, D, Masilah, E, Kay, J, Clark, CM, Montine, TJ, Lee, VM, Trojanowski, JQ. (AOP). Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathologica.
Putterman, DB, Munhall, AC, Kozell, LB, Belknap, JK, Johnson, SW. (AOP). Evaluation of levodopa dose and magnitude of dopamine depletion as risk factors for levodopa-induced dyskinesia, in a rat model of Parkinson's disease. Journal of Pharmacological Experimental Therapy.
Samii, A, Kelly, VE, Slimp, JC, Shumway-Cook, A, Goodkin, R. (AOP). Staged unilateral vs. bilateral subthalamic nucleus stimulator implantations in Parkinson disease. Movement Disorders.
Samii, A, Slimp, JC, Friedly, JL, Goodkin, R.(AOP). Spinal accessory neuropathy after deep brain stimulation for Parkinson's disease. Journal of Neurosurgery, 98, 307 - 312.
Shen, K-Z, Johnson, SW. (AOP). Multiple conductances are modulated by 5-hydroxytryptamine receptor subtypes in rat subthalamic nucleus neurons. Neuroscience.
Thompson, PD, Nutt, JG. (AOP). Higher level gait disorders. Journal of Neural Transmission.
Wu, Y-N, Martella, G, Johnson, SW. (AOP). Rotonone ehances NMDA currents by activating a tryosine kinase in rat dopamine neurons. NeuroReport.
Zabetian, CP, Hutter, CM, Factor, SA, Nutt, JG, Higgins, DS, Griffith, A, Roberts, JW, Leis, BC, Kay, DM, Yearout, D, Montimurro, JS, Edwards, KL, Samii, A, Payami, H. (AOP). Associated analysis of the MAPT H1 haplotype and subhaplotypes in Parkinson's disease. Annals of Neurology.
|
